April 2018April 2018
New Product - Gardasil 9
Gardasil 9 (human papillomavirus 9-valent vaccine) is a noninfectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52 and 58. Gardasil 9 is indicated in females aged 9 to 45 years for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by HPV types contained in the vaccine. Gardasil 9 is also indicated in males 9 to 26 years of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by HPV types contained in the vaccine. Individuals who develop symptoms indicative of hypersensitivity after receiving a dose of Gardasil 9 or Gardasil should not receive further doses of Gardasil 9. Gardasil 9 (HPV L1 protein 270 mcg) is available in a 0.5 mL prefilled syringe in a pack of 1 and 10.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au